19th Jun 2020 14:40
Oxford Biomedica PLC - Oxford-based cell therapy firm - Raises GBP40 million through the placing of 5 million shares at 800 pence each. Placing price represents 3.5% discount to Thursday closing price of 829p. Substantial shareholder Novo Holdings AS agreed to subscribe for 503,000 shares and directors agreed to subscribe for a total of 7,187 placing shares. Oxford Biomedica said new cash will help it exploit opportunities in the growing cell and gene therapy market. Following admission, the company will have 82.0 million shares in issue.
Current stock price: 818.00p
Year-to-date change: up 28%
By Ife Taiwo; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica